REFERENCES
1. Jiang B, Sun D, Sun H, et al. Prevalence, incidence, and external causes of traumatic spinal cord injury in China: a nationally representative cross-sectional survey. Front Neurol. 2021;12:784647.
3. Lu Y, Shang Z, Zhang W, et al. Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: a systematic analysis for the Global Burden of Disease 2021 study. Ageing Res Rev. 2025;103:102598.
4. Hu X, Xu W, Ren Y, et al. Spinal cord injury: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:245.
5. Tian T, Zhang S, Yang M. Recent progress and challenges in the treatment of spinal cord injury. Protein Cell. 2023;14:635-52.
6. Hellenbrand DJ, Quinn CM, Piper ZJ, Morehouse CN, Fixel JA, Hanna AS. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration. J Neuroinflammation. 2021;18:284.
7. Fouad K, Popovich PG, Kopp MA, Schwab JM. The neuroanatomical-functional paradox in spinal cord injury. Nat Rev Neurol. 2021;17:53-62.
8. Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation therapy for spinal cord injury. Nat Neurosci. 2017;20:637-47.
9. Yu T, Yang LL, Zhou Y, Wu MF, Jiao JH. Exosome-mediated repair of spinal cord injury: a promising therapeutic strategy. Stem Cell Res Ther. 2024;15:6.
10. Welsh JA, Goberdhan DCI, O’Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
11. Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013;27:31-9.
12. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8:727.
13. Zhang J, Shi W, Qu D, Yu T, Qi C, Fu H. Extracellular vesicle therapy for traumatic central nervous system disorders. Stem Cell Res Ther. 2022;13:442.
14. Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9:17.
15. Xin W, Qiang S, Jianing D, et al. Human bone marrow mesenchymal stem cell-derived exosomes attenuate blood-spinal cord barrier disruption via the TIMP2/MMP pathway after acute spinal cord injury. Mol Neurobiol. 2021;58:6490-504.
16. Li D, Xie X, Ou Y, et al. Bone marrow mesenchymal stem cells-derived exosomal miR-24-3p alleviates spinal cord injury by targeting MAPK9 to inhibit the JNK/c-Jun/c-Fos pathway. Arch Biochem Biophys. 2025;769:110434.
17. Pan Z, Zhang Y, Yan N, et al. Umbilical cord-derived exosomes alleviate spinal cord injury by regulating microglial polarization through miR-340-5p-mediated modulation of the JAK/STAT3 signaling pathway. Sci Rep. 2025;15:32226.
18. Morishima Y, Kawabori M, Yamazaki K, et al. Intravenous administration of mesenchymal stem cell-derived exosome alleviates spinal cord injury by regulating neutrophil extracellular trap formation through exosomal miR-125a-3p. Int J Mol Sci. 2024;25:2406.
19. Wang C, Zhang J, Chen W, Gao L, He J, Xia Y. Exosomal lncRNA RMRP-shuttled by olfactory mucosa-mesenchymal stem cells suppresses microglial pyroptosis to improve spinal cord injury via EIF4A3/SIRT1. Mol Neurobiol. 2025;62:8150-65.
20. Zhang M, Han X, Yan L, et al. Inflammatory response in traumatic brain and spinal cord injury: the role of XCL1-XCR1 axis and T cells. CNS Neurosci Ther. 2024;30:e14781.
21. Wang X, Yang Y, Li W, Hao M, Xu Y. Umbilical mesenchymal stem cell-derived exosomes promote spinal cord functional recovery through the miR-146b/TLR4 -mediated NF-κB p65 signaling pathway in rats. Biochem Biophys Rep. 2023;35:101497.
22. Luan Z, Liu J, Li M, Wang Y, Wang Y. Exosomes derived from umbilical cord-mesenchymal stem cells inhibit the NF-κB/MAPK signaling pathway and reduce the inflammatory response to promote recovery from spinal cord injury. J Orthop Surg Res. 2024;19:184.
23. Lei Z, Krishnamachary B, Khan NZ, et al. Spinal cord injury disrupts plasma extracellular vesicles cargoes leading to neuroinflammation in the brain and neurological dysfunction in aged male mice. Brain Behav Immun. 2024;120:584-603.
24. Gu J, Wu J, Wang C, et al. BMSCs-derived exosomes inhibit macrophage/microglia pyroptosis by increasing autophagy through the miR-21a-5p/PELI1 axis in spinal cord injury. Aging (Albany NY). 2024;16:5184-206.
25. Dong J, Gong Z, Bi H, et al. BMSC-derived exosomal miR-219-5p alleviates ferroptosis in neuronal cells caused by spinal cord injury via the UBE2Z/NRF2 pathway. Neuroscience. 2024;556:73-85.
26. Xu J, Zhang J, Liu Q, Wang B. Bone marrow mesenchymal stem cells-derived exosomes promote spinal cord injury repair through the miR-497-5p/TXNIP/NLRP3 axis. J Mol Histol. 2024;56:16.
27. Kang J, Guo Y. Human umbilical cord mesenchymal stem cells derived exosomes promote neurological function recovery in a rat spinal cord injury model. Neurochem Res. 2022;47:1532-40.
28. Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266-82.
29. Fan B, Wei Z, Feng S. Progression in translational research on spinal cord injury based on microenvironment imbalance. Bone Res. 2022;10:35.
30. Nakazaki M, Morita T, Lankford KL, Askenase PW, Kocsis JD. Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury. J Extracell Vesicles. 2021;10:e12137.
31. Xue C, Ma X, Guan X, Feng H, Zheng M, Yang X. Small extracellular vesicles derived from umbilical cord mesenchymal stem cells repair blood-spinal cord barrier disruption after spinal cord injury through down-regulation of Endothelin-1 in rats. PeerJ. 2023;11:e16311.
32. Zhou Y, Wen LL, Li YF, et al. Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis. Neural Regen Res. 2022;17:194-202.
33. Sun Y, Liu Q, Qin Y, et al. Exosomes derived from CD271+CD56+ bone marrow mesenchymal stem cell subpopoulation identified by single-cell RNA sequencing promote axon regeneration after spinal cord injury. Theranostics. 2024;14:510-27.
34. Wang Y, Han T, Guo R, et al. Micro-RNA let-7a-5p derived from mesenchymal stem cell-derived extracellular vesicles promotes the regrowth of neurons in spinal-cord-injured rats by targeting the HMGA2/SMAD2 axis. Front Mol Neurosci. 2022;15:850364.
35. Zhou W, Silva M, Feng C, et al. Exosomes derived from human placental mesenchymal stem cells enhanced the recovery of spinal cord injury by activating endogenous neurogenesis. Stem Cell Res Ther. 2021;12:174.
36. Clifford T, Finkel Z, Rodriguez B, Joseph A, Cai L. Current advancements in spinal cord injury research-glial scar formation and neural regeneration. Cells. 2023;12:853.
37. Bhatt M, Sharma M, Das B. The role of inflammatory cascade and reactive astrogliosis in glial scar formation post-spinal cord injury. Cell Mol Neurobiol. 2024;44:78.
38. Wang L, Pei S, Han L, et al. Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NFκB P65 subunit in spinal cord injury. Cell Physiol Biochem. 2018;50:1535-59.
39. Wu H, Wang Q, Liao Y, Wang S. MSC-derived exosomes deliver ZBTB4 to mediate transcriptional repression of ITIH3 in astrocytes in spinal cord injury. Brain Res Bull. 2024;212:110954.
40. Zhou Z, Li C, Bao T, et al. Exosome-shuttled miR-672-5p from anti-inflammatory microglia repair traumatic spinal cord injury by inhibiting AIM2/ASC/Caspase-1 signaling pathway mediated neuronal pyroptosis. J Neurotrauma. 2022;39:1057-74.
41. Ge X, Tang P, Rong Y, et al. Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biol. 2021;41:101932.
42. Huang JH, He H, Chen YN, et al. Exosomes derived from M2 macrophages improve angiogenesis and functional recovery after spinal cord injury through HIF-1α/VEGF axis. Brain Sci. 2022;12:1322.
43. Zhang B, Lin F, Dong J, Liu J, Ding Z, Xu J. Peripheral macrophage-derived exosomes promote repair after spinal cord injury by inducing local anti-inflammatory type microglial polarization via increasing autophagy. Int J Biol Sci. 2021;17:1339-52.
44. Peng P, Yu H, Xing C, et al. Exosomes-mediated phenotypic switch of macrophages in the immune microenvironment after spinal cord injury. Biomed Pharmacother. 2021;144:112311.
45. Ge X, Tang P, Rong Y, et al. Corrigendum to “Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury” [Redox Biol. 41 (2021) 101932/PMID:33714739]. Redox Biol. 2021;47:102121.
46. Guan X, Li C, Wang X, Yang L, Lu Y, Guo Z. Engineered M2 macrophage-derived exosomes: mechanisms and therapeutic potential in inflammation regulation and regenerative medicine. Acta Biomater. 2025;203:38-58.
47. Luo Z, Peng W, Xu Y, et al. Exosomal OTULIN from M2 macrophages promotes the recovery of spinal cord injuries via stimulating Wnt/β-catenin pathway-mediated vascular regeneration. Acta Biomater. 2021;136:519-32.
48. Li C, Wu Z, Zhou L, et al. Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury. Signal Transduct Target Ther. 2022;7:65.
49. Xiong W, Li C, Kong G, et al. Treg cell-derived exosomes miR-709 attenuates microglia pyroptosis and promotes motor function recovery after spinal cord injury. J Nanobiotechnology. 2022;20:529.
50. Kong G, Xiong W, Li C, et al. Treg cells-derived exosomes promote blood-spinal cord barrier repair and motor function recovery after spinal cord injury by delivering miR-2861. J Nanobiotechnology. 2023;21:364.
51. Qin T, Jiang T, Zhou Z, et al. Treg-microglia partnership in the injured spinal cord preserves Treg cell function and regulates microglial cholesterol metabolism. Neuron. 2025;113:3983-4000.e7.
52. Li P, Liu J, Wang Y, et al. Spatiotemporal targeted delivery of biomimetic bacterial outer membrane nanoparticles for enhanced spinal cord injury repair. Adv Mater. 2025;37:e2502795.
53. Zhang J, Hu D, Li L, et al. M2 microglia-derived exosomes promote spinal cord injury recovery in mice by alleviating A1 astrocyte activation. Mol Neurobiol. 2024;61:7009-25.
54. Li C, Qin T, Liu Y, et al. Microglia-derived exosomal microRNA-151-3p enhances functional healing after spinal cord injury by attenuating neuronal apoptosis via regulating the p53/p21/CDK1 signaling pathway. Front Cell Dev Biol. 2021;9:783017.
55. Li S, Li J, Chen G, et al. Exosomes originating from neural stem cells undergoing necroptosis participate in cellular communication by inducing TSC2 upregulation of recipient cells following spinal cord injury. Neural Regen Res. 2025;20:3273-86.
56. Han T, Song P, Wu Z, Liu Y, Ying W, Shen C. Inflammation modifies miR-21 expression within neuronal extracellular vesicles to regulate remyelination following spinal cord injury. Stem Cell Rev Rep. 2023;19:2024-37.
57. Lu Y, Chen C, Wang H, et al. Astrocyte-derived sEVs alleviate fibrosis and promote functional recovery after spinal cord injury in rats. Int Immunopharmacol. 2022;113:109322.
58. Huang JH, Chen YN, He H, Fu CH, Xu ZY, Lin FY. Schwann cells-derived exosomes promote functional recovery after spinal cord injury by promoting angiogenesis. Front Cell Neurosci. 2022;16:1077071.
59. Fan H, Chen Z, Tang HB, et al. Exosomes derived from olfactory ensheathing cells provided neuroprotection for spinal cord injury by switching the phenotype of macrophages/microglia. Bioeng Transl Med. 2022;7:e10287.
60. Sekine Y, Lindborg JA, Strittmatter SM. A proteolytic C-terminal fragment of Nogo-A (reticulon-4A) is released in exosomes and potently inhibits axon regeneration. J Biol Chem. 2020;295:2175-83.
61. Chen J, Zhang C, Li S, Li Z, Lai X, Xia Q. Exosomes derived from nerve stem cells loaded with FTY720 promote the recovery after spinal cord injury in rats by PTEN/AKT signal pathway. J Immunol Res. 2021;2021:8100298.
62. Jiang D, Gong F, Ge X, et al. Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J Nanobiotechnology. 2020;18:105.
63. Sun H, Cao X, Gong A, et al. Extracellular vesicles derived from astrocytes facilitated neurite elongation by activating the Hippo pathway. Exp Cell Res. 2022;411:112937.
64. Rong Y, Ji C, Wang Z, et al. Small extracellular vesicles encapsulating CCL2 from activated astrocytes induce microglial activation and neuronal apoptosis after traumatic spinal cord injury. J Neuroinflammation. 2021;18:196.
65. Singh N, Pathak Z, Kumar H. Rab27a-mediated extracellular vesicle release drives astrocytic CSPG secretion and glial scarring in spinal cord injury. Biomater Adv. 2025;176:214357.
66. Pan D, Li Y, Yang F, et al. Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury. J Neuroinflammation. 2021;18:172.
67. Pan D, Zhu S, Zhang W, et al. Autophagy induced by Schwann cell-derived exosomes promotes recovery after spinal cord injury in rats. Biotechnol Lett. 2022;44:129-42.
68. Ren J, Zhu B, Gu G, et al. Schwann cell-derived exosomes containing MFG-E8 modify macrophage/microglial polarization for attenuating inflammation via the SOCS3/STAT3 pathway after spinal cord injury. Cell Death Dis. 2023;14:70.
69. Xu B, Zhou Z, Fang J, et al. Exosomes derived from schwann cells alleviate mitochondrial dysfunction and necroptosis after spinal cord injury via AMPK signaling pathway-mediated mitophagy. Free Radic Biol Med. 2023;208:319-33.
70. Zhu S, Ma H, Hou M, Li H, Ning G. Schwann cell-derived exosomes induced axon growth after spinal cord injury by decreasing pTP-σ activation on CSPGs via the Rho/ROCK pathway. Neurochem Res. 2024;49:2120-30.
71. Tu YK, Hsueh YH. Extracellular vesicles isolated from human olfactory ensheathing cells enhance the viability of neural progenitor cells. Neurol Res. 2020;42:959-67.
72. Yang S, Xue B, Zhang Y, et al. Engineered extracellular vesicles from antler blastema progenitor cells: a therapeutic choice for spinal cord injury. ACS Nano. 2025;19:5995-6013.
73. Li C, Qin T, Jin Y, et al. Cerebrospinal fluid-derived extracellular vesicles after spinal cord injury promote vascular regeneration via PI3K/AKT signaling pathway. J Orthop Translat. 2023;39:124-34.
74. Ge X, Zhou Z, Yang S, et al. Exosomal USP13 derived from microvascular endothelial cells regulates immune microenvironment and improves functional recovery after spinal cord injury by stabilizing IκBα. Cell Biosci. 2023;13:55.
75. Lin J, Huang T, Gao T, Zheng X. [Experimental study of endothelial progenitor cells derived small extracellular vesicles for spinal cord injury repair in mice]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021;35:488-95.
76. Abbas A, Huang X, Ullah A, et al. Enhanced spinal cord repair using bioengineered induced pluripotent stem cell-derived exosomes loaded with miRNA. Mol Med. 2024;30:168.
77. Wu C, Zhu Q, Yao Y, Shi Z, Jin C, Chen L. Exosome miR-23a-3p from osteoblast alleviates spinal cord ischemia/reperfusion injury by down-regulating KLF3-activated CCNL2 transcription. Dev Neurosci. 2022;44:121-30.
78. Gao P, Yi J, Chen W, et al. Pericyte-derived exosomal miR-210 improves mitochondrial function and inhibits lipid peroxidation in vascular endothelial cells after traumatic spinal cord injury by activating JAK1/STAT3 signaling pathway. J Nanobiotechnology. 2023;21:452.
79. Chen J, Wu J, Mu J, et al. An antioxidative sophora exosome-encapsulated hydrogel promotes spinal cord repair by regulating oxidative stress microenvironment. Nanomedicine. 2023;47:102625.
80. Chen H, Sun H, Yang Y, et al. Engineered melatonin-pretreated plasma exosomes repair traumatic spinal cord injury by regulating miR-138-5p/SOX4 axis mediated microglia polarization. J Orthop Translat. 2024;49:230-45.
81. Akbari-Gharalari N, Aliyari-Serej Z, Ghahremani-Nasab M, et al. Cerebrolysin-loaded platelet-rich plasma exosomes: restoring immune homeostasis via TNF-α/IL-10 modulation and apoptosis targeting for spinal cord injury repair. J Spinal Cord Med. 2026;49:375-87.
82. Cai H, Zhang Y, Meng F, Li Y. Effects of spinal cord injury associated exosomes delivered tRF-41 on the progression of spinal cord injury progression. Genomics. 2024;116:110885.
83. Fang Y, Chen W, Zhang Y, et al. Spinal cord injury-derived exosomes exacerbate damage: miR-155-5p mediates inflammatory responses. Neural Regen Res. 2026;21:2514-22.
84. Ijaz S, Mohammed I, Gholaminejhad M, Mokhtari T, Akbari M, Hassanzadeh G. Modulating pro-inflammatory cytokines, tissue damage magnitude, and motor deficit in spinal cord injury with subventricular zone-derived extracellular vesicles. J Mol Neurosci. 2020;70:458-66.
85. Yuan F, Peng W, Yang Y, et al. Endothelial progenitor cell-derived exosomes promote anti-inflammatory macrophages via SOCS3/JAK2/STAT3 axis and improve the outcome of spinal cord injury. J Neuroinflammation. 2023;20:156.
86. Li J, Jing Y, Bai F, et al. Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury. Front Pharmacol. 2022;13:1078761.
87. Liu J, Kong G, Lu C, et al. IPSC-NSCs-derived exosomal let-7b-5p improves motor function after spinal cord Injury by modulating microglial/macrophage pyroptosis. J Nanobiotechnology. 2024;22:403.
88. Wang Q, Liu K, Cao X, et al. Plant-derived exosomes extracted from Lycium barbarum L. loaded with isoliquiritigenin to promote spinal cord injury repair based on 3D printed bionic scaffold. Bioeng Transl Med. 2024;9:e10646.
89. Ran N, Li W, Zhang R, et al. Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury. Bioact Mater. 2023;25:766-82.
90. Nie X, Liu Y, Yuan T, et al. Platelet-rich plasma-derived exosomes promote blood-spinal cord barrier repair and attenuate neuroinflammation after spinal cord injury. J Nanobiotechnology. 2024;22:456.
91. Huang J, Wu C, Xu G, et al. The decreased expression of miR-429 in plasma exosomes after spinal cord injury inhibits neuronal apoptosis by mediating the PTEN/PI3K/Akt pathway. Ann Transl Med. 2022;10:6.
92. Memo C, Parisse P, Amoriello R, et al. Extracellular vesicles released by LPS-stimulated spinal organotypic slices spread neuroinflammation into naïve slices through connexin43 hemichannel opening and astrocyte aberrant calcium dynamics. Front Cell Neurosci. 2024;18:1433309.
93. Yang D, Wei H, Sheng Y, et al. Circ_0006640 transferred by bone marrow-mesenchymal stem cell-exosomes suppresses lipopolysaccharide-induced apoptotic, inflammatory and oxidative injury in spinal cord injury. J Orthop Surg Res. 2024;19:50.
94. Lei Z, Krishnamachary B, Ritzel RM, et al. Age-related changes in plasma extracellular vesicles influence neuroinflammation in the brain and neurological outcome after traumatic spinal cord injury. Res Sq. 2023:rs.3.rs-2821858.
95. Li Y, Khan N, Ritzel RM, et al. Sexually dimorphic extracellular vesicle responses after chronic spinal cord injury are associated with neuroinflammation and neurodegeneration in the aged brain. J Neuroinflammation. 2023;20:197.
96. Huang T, Jia Z, Fang L, et al. Extracellular vesicle-derived miR-511-3p from hypoxia preconditioned adipose mesenchymal stem cells ameliorates spinal cord injury through the TRAF6/S1P axis. Brain Res Bull. 2022;180:73-85.
97. Li M, Zhang T, Li P, et al. IL-4-primed human umbilical cord mesenchymal stem cells-derived extracellular vesicles facilitate recovery in spinal cord injury via the miR-21-5p/PDCD4-mediated shifting of macrophage M1/M2 polarization. Life Sci. 2025;364:123441.
98. Chen G, Tong K, Li S, et al. Extracellular vesicles released by transforming growth factor-beta 1-preconditional mesenchymal stem cells promote recovery in mice with spinal cord injury. Bioact Mater. 2024;35:135-49.
99. Fan Y, Li Y, Huang S, Xu H, Li H, Liu B. Resveratrol-primed exosomes strongly promote the recovery of motor function in SCI rats by activating autophagy and inhibiting apoptosis via the PI3K signaling pathway. Neurosci Lett. 2020;736:135262.
100. Rong Y, Wang J, Hu T, et al. Ginsenoside Rg1 regulates immune microenvironment and neurological recovery after spinal cord injury through MYCBP2 delivery via neuronal cell-derived extracellular vesicles. Adv Sci. 2024;11:e2402114.
101. Wang Y, Yi H, Huang K, et al. 2-Mercaptoethanol enhances the yield of exosomes showing therapeutic potency in alleviating spinal cord injury mice. Life Sci. 2025;364:123451.
102. Xiong W, Tian H, Li Z, Peng Z, Wang Y. Curcumin-primed umbilical cord mesenchymal stem cells-derived extracellular vesicles improve motor functional recovery of mice with complete spinal cord injury by reducing inflammation and enhancing axonal regeneration. Neurochem Res. 2023;48:1334-46.
103. Li K, Liu Z, Wu P, et al. Micro electrical fields induced MSC-sEVs attenuate neuronal cell apoptosis by activating autophagy via lncRNA MALAT1/miR-22-3p/SIRT1/AMPK axis in spinal cord injury. J Nanobiotechnology. 2023;21:451.
104. Li L, Mu J, Zhang Y, et al. Stimulation by exosomes from hypoxia preconditioned human umbilical vein endothelial cells facilitates mesenchymal stem cells angiogenic function for spinal cord repair. ACS Nano. 2022;16:10811-23.
105. Shao M, Jin M, Xu S, et al. Exosomes from long noncoding RNA-Gm37494-ADSCs repair spinal cord injury via shifting microglial M1/M2 polarization. Inflammation. 2020;43:1536-47.
106. Liang Y, Wu JH, Zhu JH, Yang H. Exosomes secreted by hypoxia-pre-conditioned adipose-derived mesenchymal stem cells reduce neuronal apoptosis in rats with spinal cord injury. J Neurotrauma. 2022;39:701-14.
107. Ye Y, Hao J, Hong Z, et al. Downregulation of microRNA-145-5p in activated microglial exosomes promotes astrocyte proliferation by removal of Smad3 inhibition. Neurochem Res. 2022;47:382-93.
108. Kong G, Liu J, Wang J, et al. Engineered extracellular vesicles modified by angiopep-2 peptide promote targeted repair of spinal cord injury and brain inflammation. ACS Nano. 2025;19:4582-600.
109. Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11:3183-95.
110. Yang C, Xu T, Lu Y, et al. Quercetin-loaded human umbilical cord mesenchymal stem cell-derived sEVs for spinal cord injury recovery. Neuroscience. 2024;552:14-28.
111. Wang B, Chang M, Zhang R, et al. Spinal cord injury target-immunotherapy with TNF-α autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR/Cas9 plasmid. Biomater Adv. 2022;133:112624.
112. Xie Y, Sun Y, Liu Y, et al. Targeted delivery of RGD-CD146+CD271+ human umbilical cord mesenchymal stem cell-derived exosomes promotes blood-spinal cord barrier repair after spinal cord injury. ACS Nano. 2023;17:18008-24.
113. Shaikh II, Bhandari R, Singh S, et al. Therapeutic potential of EVs loaded with CB2 receptor agonist in spinal cord injury via the Nrf2/HO-1 pathway. Redox Rep. 2024;29:2420572.
114. Rong Y, Wang Z, Tang P, et al. Engineered extracellular vesicles for delivery of siRNA promoting targeted repair of traumatic spinal cord injury. Bioact Mater. 2023;23:328-42.
115. Gao ZS, Zhang CJ, Xia N, et al. Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy. Acta Biomater. 2021;126:211-23.
116. Qin T, Qin Y, Wen H, et al. Hypoxic neural stem cells enhance spinal cord repair through HIF-1a/RAB17-driven extracellular vesicle release. J Extracell Vesicles. 2025;14:e70126.
117. Akbari-Gharalari N, Ghahremani-Nasab M, Naderi R, et al. Improvement of spinal cord injury symptoms by targeting the Bax/Bcl2 pathway and modulating TNF-α/IL-10 using Platelet-Rich Plasma exosomes loaded with dexamethasone. AIMS Neurosci. 2023;10:332-53.
118. Huang W, Qu M, Li L, Liu T, Lin M, Yu X. SiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats. Stem Cell Res Ther. 2021;12:334.
119. Huang W, Lin M, Yang C, et al. Rat bone mesenchymal stem cell-derived exosomes loaded with miR-494 promoting neurofilament regeneration and behavioral function recovery after spinal cord injury. Oxid Med Cell Longev. 2021;2021:1634917.
120. Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12:1416.
121. Han Y, Jones TW, Dutta S, et al. Overview and update on methods for cargo loading into extracellular vesicles. Processes. 2021;9:356.
122. Johnsen KB, Gudbergsson JM, Skov MN, et al. Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology. 2016;68:2125-38.
123. Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18-30.
124. Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J. Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 2020;17:1723-33.
125. Guo S, Perets N, Betzer O, et al. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury. ACS Nano. 2019;13:10015-28.
126. for Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina. J Extracell Biol. 2022;1:e67.
127. Kooijmans SAA, Fliervoet LAL, van der Meel R, et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77-85.
128. Ben XY, Wang YR, Zheng HH, et al. Construction of exosomes that overexpress CD47 and evaluation of their immune escape. Front Bioeng Biotechnol. 2022;10:936951.
129. Demeule M, Currie JC, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem. 2008;106:1534-44.
130. Li L, Zhang Y, Mu J, et al. Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury. Nano Lett. 2020;20:4298-305.
131. Wang G, Li Q, Liu S, et al. An injectable decellularized extracellular matrix hydrogel with cortical neuron-derived exosomes enhances tissue repair following traumatic spinal cord injury. Mater Today Bio. 2024;28:101250.
132. Han M, Yang H, Lu X, et al. Three-dimensional-cultured MSC-derived exosome-hydrogel hybrid microneedle array patch for spinal cord repair. Nano Lett. 2022;22:6391-401.
133. Afsartala Z, Hadjighassem M, Shirian S, et al. The effect of collagen and fibrin hydrogels encapsulated with adipose tissue mesenchymal stem cell-derived exosomes for treatment of spinal cord injury in a rat model. Iran J Biotechnol. 2023;21:e3505.
134. Wang C, Wang M, Xia K, et al. A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury. Bioact Mater. 2021;6:2523-34.
135. Wang S, Wang R, Chen J, et al. Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury. J Control Release. 2023;363:27-42.
136. Lin Y, Guo Q, Liu Q, et al. An injectable responsive exosome-releasing hydrogel based on sodium alginate restores motor and bladder function by alleviating the injury microenvironment and facilitating distal nerve repair. Int J Biol Macromol. 2025;304:140819.
137. Dong X, Lu Y, Hu Q, et al. Engineered exosome-loaded silk fibroin composite hydrogels promote tissue repair in spinal cord injury via immune checkpoint blockade. Small. 2025;21:e2412170.
138. Cheng J, Chen Z, Liu C, et al. Bone mesenchymal stem cell-derived exosome-loaded injectable hydrogel for minimally invasive treatment of spinal cord injury. Nanomedicine. 2021;16:1567-79.
139. Fan L, Liu C, Chen X, et al. Exosomes-loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth. Adv Sci. 2022;9:e2105586.
140. Deng M, Xie P, Xue H, et al. Decellularized tissue matrices hydrogels functionalized with extracellular vesicles promote macrophage reprogramming and neural stem cell differentiation for spinal cord injury repair. J Nanobiotechnology. 2025;23:139.
141. Nishida H, Matsuura H, Yoshizaki K, et al. Sustained release of canine mesenchymal stem/stromal cell-derived extracellular vesicles rescues motor function in rodent spinal cord injury models. Regen Ther. 2025;30:164-72.
142. Liu X, Zhang L, Xu Z, et al. A functionalized collagen-I scaffold delivers microRNA 21-loaded exosomes for spinal cord injury repair. Acta Biomater. 2022;154:385-400.
143. Cao J, Zhang X, Guo J, et al. An engineering-reinforced extracellular vesicle-integrated hydrogel with an ROS-responsive release pattern mitigates spinal cord injury. Sci Adv. 2025;11:eads3398.
144. Wang Y, Liu J, Li P, et al. Nasal delivery of engineered exosomes via a thermo-sensitive hydrogel depot reprograms glial cells for spinal cord repair. Adv Sci. 2025;12:e04486.
145. Li X, Zhang J, Zhang Y, et al. Conjugated therapy with coaxially printed neural stem cell-laden microfibers and umbilical cord mesenchymal stem cell derived exosomes on complete transactional spinal cord defects. Mater Today Bio. 2025;32:101639.
146. Liu W, Liu Q, Li Z, et al. Multifunctional magneto-electric and exosome-loaded hydrogel enhances neuronal differentiation and immunoregulation through remote non-invasive electrical stimulation for neurological recovery after spinal cord injury. Bioact Mater. 2025;48:510-28.
147. Zhang L, Fan C, Hao W, et al. NSCs migration promoted and drug delivered exosomes-collagen scaffold via a bio-specific peptide for one-step spinal cord injury repair. Adv Healthc Mater. 2021;10:e2001896.
148. Poongodi R, Yang TH, Huang YH, et al. Stem cell exosome-loaded Gelfoam improves locomotor dysfunction and neuropathic pain in a rat model of spinal cord injury. Stem Cell Res Ther. 2024;15:143.
149. Xiao Y, Hu X, Jiang P, Qi Z. Thermos-responsive hydrogel system encapsulated engineered exosomes attenuate inflammation and oxidative damage in acute spinal cord injury. Front Bioeng Biotechnol. 2023;11:1216878.
150. Zhang X, Cao J, Wu J, et al. Local delivery of mesenchymal stem cell-extruded nanovesicles through a bio-responsive scaffold for acute spinal cord injury treatment. Int J Pharm. 2025;671:125222.
151. Fang A, Wang Y, Guan N, et al. Porous microneedle patch with sustained delivery of extracellular vesicles mitigates severe spinal cord injury. Nat Commun. 2023;14:4011.
152. Mu J, Wu J, Cao J, et al. Rapid and effective treatment of traumatic spinal cord injury using stem cell derived exosomes. Asian J Pharm Sci. 2021;16:806-15.
153. Bai L, Gao J, Zhang P, Lin S, Zhang C. Immunotherapy of M2 macrophage derived from exosome-based nanoparticles for spinal cord injury. Int Immunopharmacol. 2024;132:111983.
154. Guan P, Fan L, Zhu Z, et al. M2 microglia-derived exosome-loaded electroconductive hydrogel for enhancing neurological recovery after spinal cord injury. J Nanobiotechnology. 2024;22:8.
155. Huang T, Mu J, Wu J, et al. A functionalized scaffold facilitates neurites extension for spinal cord injury therapy. Small. 2024;20:e2401020.
156. Ma L, Yang Y, Chen T, Ma L, Deng Q. Developing an NT3-loaded exosomal biodegradable conductive hydrogel combined with EA for targeted treatment of spinal cord injury. Mater Today Bio. 2025;33:101988.
157. Song P, Han T, Wu Z, et al. Transplantation of neural stem cells loaded in an IGF-1 bioactive supramolecular nanofiber hydrogel for the effective treatment of spinal cord injury. Adv Sci. 2024;11:e2306577.
158. Zhu B, Gu G, Ren J, et al. Schwann cell-derived exosomes and methylprednisolone composite patch for spinal cord injury repair. ACS Nano. 2023;17:22928-43.
159. Liu Z, Guo S, Dong L, et al. A tannic acid doped hydrogel with small extracellular vesicles derived from mesenchymal stem cells promotes spinal cord repair by regulating reactive oxygen species microenvironment. Mater Today Bio. 2022;16:100425.
160. Nazerian Y, Nazerian A, Mohamadi-Jahani F, Sodeifi P, Jafarian M, Javadi SAH. Hydrogel-encapsulated extracellular vesicles for the regeneration of spinal cord injury. Front Neurosci. 2023;17:1309172.
161. Deng H, Wang J, An R. Hyaluronic acid-based hydrogels: as an exosome delivery system in bone regeneration. Front Pharmacol. 2023;14:1131001.
162. Liu J, Liu D, Ma R, et al. Advancing recovery post‐spinal cord injury: nanoparticle‐mediated reprogramming of peripheral macrophages. Adv Funct Mater. 2024;34:2407958.
163. Hong JY, Kim SH, Seo Y, et al. Self-assembling peptide gels promote angiogenesis and functional recovery after spinal cord injury in rats. J Tissue Eng. 2022;13:20417314221086491.
164. Farrukh A, Ortega F, Fan W, et al. Bifunctional hydrogels containing the laminin motif IKVAV promote neurogenesis. Stem Cell Reports. 2017;9:1432-40.
